Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=e0340c55da&cb=584241045"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538188057&cs=e0340c55da&cb=584241045" border="0" alt=""></a>

#voxilaprevir

Vosevi

AbbVie and Gilead Get European Recommendation for New Hepatitis C Combos

Maviret and Vosevi were highly effective and well tolerated in clinical trials.

Gilead Files for FDA OK of New All-Genotype Hepatitis C Treatment

The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.

Excellent Results for Gilead’s Experimental Regimen for All Hep C Genotypes

Gilead has tested the addition of the investigational voxilaprevir to its already approved Epclusa (sofosbuvir/velpatasvir).

Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=e0340c55da&cb=199967019"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538188053&cs=e0340c55da&cb=199967019" border="0" alt=""></a>